Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 207

1.

Definition, aims, and implementation of GA2 LEN/HAEi Angioedema Centers of Reference and Excellence.

Maurer M, Aberer W, Agondi R, Al-Ahmad M, Al-Nesf MA, Ansotegui I, Arnaout R, Arruda LK, Asero R, Aygören-Pürsün E, Banerji A, Bauer A, Ben-Shoshan M, Berardi A, Bernstein JA, Betschel S, Bindslev-Jensen C, Bizjak M, Boccon-Gibod I, Bork K, Bouillet L, Boysen HB, Brodszki N, Broesby-Olsen S, Busse P, Buttgereit T, Bygum A, Caballero T, Campos RA, Cancian M, Cherrez-Ojeda I, Cohn DM, Costa C, Craig T, Criado PR, Criado RF, Csuka D, Dissemond J, Du-Thanh A, Ensina LF, Ertaş R, Fabiani JE, Fantini C, Farkas H, Ferrucci SM, Figueras-Nart I, Fili NL, Fomina D, Fukunaga A, Gelincik A, Giménez-Arnau A, Godse K, Gompels M, Gonçalo M, Gotua M, Gower R, Grumach AS, Guidos-Fogelbach G, Hide M, Ilina N, Inomata N, Jakob T, Josviack DO, Kang HR, Kaplan A, Kasperska-Zając A, Katelaris C, Kessel A, Kleinheinz A, Kocatürk E, Košnik M, Krasowska D, Kulthanan K, Kumaran MS, Larco JI, Longhurst HJ, Lumry W, MacGinnitie A, Magerl M, Makris MP, Malbrán A, Marsland A, Martinez-Saguer I, Medina IV, Meshkova R, Metz M, Nasr I, Nicolay J, Nishigori C, Ohsawa I, Özyurt K, Papadopoulos NG, Parisi CA, Peter JG, Pfützner W, Popov T, Prior N, Ramon GD, Reich A, Reshef A, Riedl MA, Ritchie B, Röckmann-Helmbach H, Rudenko M, Salman A, Sanchez-Borges M, Schmid-Grendelmeier P, Serpa FS, Serra-Baldrich E, Sheikh FR, Smith W, Soria A, Staubach P, Steiner UC, Stobiecki M, Sussman G, Tagka A, Thomsen SF, Treudler R, Valle S, van Doorn M, Varga L, Vázquez DO, Wagner N, Wang L, Weber-Chrysochoou C, Ye YM, Zalewska-Janowska A, Zanichelli A, Zhao Z, Zhi Y, Zuberbier T, Zwiener RD, Castaldo A.

Allergy. 2020 Apr 5. doi: 10.1111/all.14293. [Epub ahead of print] No abstract available.

PMID:
32248571
2.

Fatal outcome of malignant transformation of hidradenitis suppurativa: A case report and literature review.

Nielsen VW, Jørgensen AR, Thomsen SF.

Clin Case Rep. 2020 Feb 6;8(3):504-507. doi: 10.1002/ccr3.2608. eCollection 2020 Mar.

3.

Evaluation of Association Between Oral and Topical Terbinafine Use in Pregnancy and Risk of Major Malformations and Spontaneous Abortion.

Andersson NW, Thomsen SF, Andersen JT.

JAMA Dermatol. 2020 Mar 4. doi: 10.1001/jamadermatol.2020.0142. [Epub ahead of print]

PMID:
32129793
4.

Virtual Clinical Trials: Perspectives in Dermatology.

Ali Z, Zibert JR, Thomsen SF.

Dermatology. 2020 Mar 3:1-8. doi: 10.1159/000506418. [Epub ahead of print] Review.

5.

Risk of comorbidities in patients diagnosed with chronic urticaria: A nationwide registry-study.

Ghazanfar MN, Kibsgaard L, Thomsen SF, Vestergaard C.

World Allergy Organ J. 2020 Jan 25;13(1):100097. doi: 10.1016/j.waojou.2019.100097. eCollection 2020 Jan.

6.

Events during the 3 Months Immediately Preceding Onset of Chronic Urticaria: A Questionnaire Study.

Ali S, Ghazanfar MN, Holm JG, Thomsen SF.

Dermatology. 2020 Jan 28:1-3. doi: 10.1159/000505514. [Epub ahead of print] No abstract available.

7.

Dupilumab for prurigo nodularis: Case series and review of the literature.

Holm JG, Agner T, Sand C, Thomsen SF.

Dermatol Ther. 2020 Mar;33(2):e13222. doi: 10.1111/dth.13222. Epub 2020 Jan 16. Review.

PMID:
31917498
8.

Factors affecting quality of life in patients with hidradenitis suppurativa.

Jørgensen AR, Holm JG, Ghazanfar MN, Yao Y, Ring HC, Thomsen SF.

Arch Dermatol Res. 2019 Dec 17. doi: 10.1007/s00403-019-02025-5. [Epub ahead of print]

PMID:
31848682
9.

Predictive Metagenomic Analysis Reveals a Role of Cutaneous Dysbiosis in the Development of Hidradenitis Suppurativa.

Ring HC, Thorsen J, Jørgensen AH, Bay L, Bjarnsholt T, Fuursted K, Thomsen SF, Jemec GB.

J Invest Dermatol. 2019 Dec 12. pii: S0022-202X(19)33476-1. doi: 10.1016/j.jid.2019.11.011. [Epub ahead of print] No abstract available.

PMID:
31838125
10.

Studies on the role of diet in the management of hidradenitis suppurativa are needed.

Eiken HC, Holm JG, Thomsen SF.

J Am Acad Dermatol. 2020 Apr;82(4):e137-e138. doi: 10.1016/j.jaad.2019.10.137. Epub 2019 Dec 10. No abstract available.

PMID:
31836565
11.
12.

Predicting the long-term outcomes of biologics in patients with psoriasis using machine learning.

Emam S, Du AX, Surmanowicz P, Thomsen SF, Greiner R, Gniadecki R.

Br J Dermatol. 2019 Nov 28. doi: 10.1111/bjd.18741. [Epub ahead of print] No abstract available.

PMID:
31778205
13.

Work productivity and activity impairment in patients with hidradenitis suppurativa: a cross-sectional study.

Yao Y, Jørgensen AR, Thomsen SF.

Int J Dermatol. 2020 Mar;59(3):333-340. doi: 10.1111/ijd.14706. Epub 2019 Nov 17.

PMID:
31736064
14.

Clinical Management of Atopic Dermatitis in Adults: Mapping of Expert Opinion in 4 Nordic Countries using a Modified Delphi Process.

Thyssen JP, Berents T, Bradley M, Deleuran M, Grimstad Ø, Korhonen L, Langeland T, Särnhult T, Thomsen SF, Thune T, Wahlgren CF, Vestergaard C, Kobyletzki LB, Remitz A.

Acta Derm Venereol. 2020 Jan 7;100(1):adv00015. doi: 10.2340/00015555-3369.

15.

The prevalence of atopic dermatitis in adults: systematic review on population studies.

Mathiesen SM, Thomsen SF.

Dermatol Online J. 2019 Aug 15;25(8). pii: 13030/qt6nj0x5k0.

16.

The risk of asthma is increased among women with polycystic ovary syndrome: a twin study.

Zierau L, Meteran H, Backer V, Lindenberg S, Skytthe A, Thomsen SF.

ERJ Open Res. 2019 Sep 16;5(3). pii: 00018-2018. doi: 10.1183/23120541.00018-2018. eCollection 2019 Jul.

17.

Clinical, microbiological, immunological and imaging characteristics of tunnels and fistulas in hidradenitis suppurativa and Crohn's disease.

Jørgensen AR, Thomsen SF, Karmisholt KE, Ring HC.

Exp Dermatol. 2020 Feb;29(2):118-123. doi: 10.1111/exd.14036. Epub 2019 Oct 1. Review.

PMID:
31519056
18.

Burden, predictors and temporal relationships of comorbidities in patients with hidradenitis suppurativa: a hospital-based cohort study.

Jørgensen AR, Yao Y, Ghazanfar MN, Ring HC, Thomsen SF.

J Eur Acad Dermatol Venereol. 2020 Mar;34(3):565-573. doi: 10.1111/jdv.15904. Epub 2019 Sep 16.

PMID:
31442338
19.

Atopic dermatitis is associated with increased use of social benefits: a register-based cohort study.

Slagor RM, Nørreslet LB, Ebbehøj NE, Bonde JP, Thomsen SF, Agner T.

J Eur Acad Dermatol Venereol. 2020 Mar;34(3):549-557. doi: 10.1111/jdv.15902. Epub 2019 Nov 14.

PMID:
31442333
20.

Emerging Terbinafine Resistance in Trichophyton: Clinical Characteristics, Squalene Epoxidase Gene Mutations, and a Reliable EUCAST Method for Detection.

Saunte DML, Hare RK, Jørgensen KM, Jørgensen R, Deleuran M, Zachariae CO, Thomsen SF, Bjørnskov-Halkier L, Kofoed K, Arendrup MC.

Antimicrob Agents Chemother. 2019 Sep 23;63(10). pii: e01126-19. doi: 10.1128/AAC.01126-19. Print 2019 Oct.

21.

Sequential treatment with secukinumab and ustekinumab in a patient with severe psoriasis and recent history of cerebral malignant melanoma metastasis.

Ghazanfar MN, Karlsmark T, Danielsen PL, Thomsen SF.

Clin Case Rep. 2019 Jun 3;7(7):1350-1351. doi: 10.1002/ccr3.2225. eCollection 2019 Jul.

22.

Socioeconomic Costs and Health Inequalities from Psoriasis: A Cohort Study.

Thomsen SF, Skov L, Dodge R, Hedegaard MS, Kjellberg J.

Dermatology. 2019;235(5):372-379. doi: 10.1159/000499924. Epub 2019 Jun 25.

PMID:
31238322
23.

Use of the Patient Benefit Index to monitor treatment of chronic spontaneous urticaria with omalizumab.

Chodziuk AC, Ghazanfar MN, Thomsen SF.

Dermatol Ther. 2019 May;32(3):e12902. doi: 10.1111/dth.12902. Epub 2019 Apr 23. No abstract available.

PMID:
30964569
24.

Treatment of atopic dermatitis with dupilumab: experience from a tertiary referral centre.

Olesen CM, Holm JG, Nørreslet LB, Serup JV, Thomsen SF, Agner T.

J Eur Acad Dermatol Venereol. 2019 Aug;33(8):1562-1568. doi: 10.1111/jdv.15609. Epub 2019 Apr 29.

PMID:
30959559
25.

IgE-Mediated Multimorbidities in Allergic Asthma and the Potential for Omalizumab Therapy.

Humbert M, Bousquet J, Bachert C, Palomares O, Pfister P, Kottakis I, Jaumont X, Thomsen SF, Papadopoulos NG.

J Allergy Clin Immunol Pract. 2019 May - Jun;7(5):1418-1429. doi: 10.1016/j.jaip.2019.02.030. Epub 2019 Mar 27. Review.

26.

Biologics for chronic inflammatory skin diseases: an update for the clinician.

Yao Y, Ravn Jørgensen AH, Thomsen SF.

J Dermatolog Treat. 2020 Mar;31(2):108-130. doi: 10.1080/09546634.2019.1589643. Epub 2019 Mar 25. Review.

PMID:
30827126
27.

Association Between Chronic Obstructive Pulmonary Disease and Type 2 Diabetes: A Systematic Review and Meta-Analysis.

Rasmussen SM, Brok J, Backer V, Thomsen SF, Meteran H.

COPD. 2018 Oct;15(5):526-535. doi: 10.1080/15412555.2018.1532495.

PMID:
30822245
28.

Isotretinoin and hidradenitis suppurativa.

Jørgensen AR, Thomsen SF, Ring HC.

Clin Exp Dermatol. 2019 Jun;44(4):e155-e156. doi: 10.1111/ced.13953. Epub 2019 Mar 21. No abstract available.

PMID:
30802991
29.

Determinants of disease severity among patients with atopic dermatitis: association with components of the atopic march.

Holm JG, Agner T, Clausen ML, Thomsen SF.

Arch Dermatol Res. 2019 Apr;311(3):173-182. doi: 10.1007/s00403-019-01895-z. Epub 2019 Feb 15.

PMID:
30770978
30.

Use of Complementary and Alternative Therapies in Outpatients with Atopic Dermatitis from a Dermatological University Department.

Holm JG, Clausen ML, Agner T, Thomsen SF.

Dermatology. 2019;235(3):189-195. doi: 10.1159/000496274. Epub 2019 Feb 13.

PMID:
30759429
31.

Omalizumab for atopic dermatitis: evidence for and against its use.

Holm JG, Thomsen SF.

G Ital Dermatol Venereol. 2019 Aug;154(4):480-487. doi: 10.23736/S0392-0488.19.06302-8. Epub 2019 Feb 4.

PMID:
30717578
32.

Effectiveness and safety of switching to biosimilar infliximab and etanercept in patients with psoriasis.

Lund T, Sand C, Gniadecki R, Thomsen SF.

Dermatol Ther. 2019 May;32(3):e12846. doi: 10.1111/dth.12846. Epub 2019 Feb 22. No abstract available.

PMID:
30697879
33.

Type 2 diabetes and psoriasis: links and risks.

Holm JG, Thomsen SF.

Psoriasis (Auckl). 2019 Jan 17;9:1-6. doi: 10.2147/PTT.S159163. eCollection 2019. Review.

34.

D-dimer as a potential blood biomarker for disease activity and treatment response in chronic urticaria: a focused review.

Ghazanfar MN, Thomsen SF.

Eur J Dermatol. 2018 Dec 1;28(6):731-735. doi: 10.1684/ejd.2018.3443. Review.

PMID:
30530404
35.

Hidradenitis Suppurativa: Causes, Features, and Current Treatments.

Vinkel C, Thomsen SF.

J Clin Aesthet Dermatol. 2018 Oct;11(10):17-23. Epub 2018 Oct 1. Review.

36.

Acne vulgaris in patients with hidradenitis suppurativa.

Ravn Jørgensen AH, Ring HC, Thomsen SF.

J Am Acad Dermatol. 2019 May;80(5):e129-e130. doi: 10.1016/j.jaad.2018.11.021. Epub 2018 Nov 17. No abstract available.

PMID:
30458210
37.

Asthma severity and fertility outcome in women with polycystic ovary syndrome: a registry-based study.

Zierau L, Cortes R, Thomsen SF, Jimenez-Solem E, Lindenberg S, Backer V.

ERJ Open Res. 2018 Nov 5;4(4). pii: 00138-2017. doi: 10.1183/23120541.00138-2017. eCollection 2018 Oct.

38.

Self-reported intake of fruit and vegetables and risk of chronic obstructive pulmonary disease: A nation-wide twin study.

Meteran H, Thomsen SF, Miller MR, Hjelmborg J, Sigsgaard T, Backer V.

Respir Med. 2018 Nov;144:16-21. doi: 10.1016/j.rmed.2018.09.013. Epub 2018 Sep 20.

PMID:
30366579
39.

Clinical phenotypes of hidradenitis suppurativa.

Jørgensen AR, Thomsen SF, Ring HC.

J Eur Acad Dermatol Venereol. 2019 Mar;33(3):e111-e112. doi: 10.1111/jdv.15276. Epub 2018 Oct 24. No abstract available.

PMID:
30288802
40.

Sample size estimation practices in research protocols submitted to Danish scientific ethics committees.

Flege MM, Thomsen SF.

Contemp Clin Trials Commun. 2018 Aug 15;11:165-169. doi: 10.1016/j.conctc.2018.08.003. eCollection 2018 Sep.

41.

Combined treatment with omalizumab and etanercept in a patient with chronic spontaneous urticaria and rheumatoid arthritis.

Ghazanfar MN, Thomsen SF.

J Dermatolog Treat. 2019 Jun;30(4):387-388. doi: 10.1080/09546634.2018.1515465. Epub 2018 Sep 25.

PMID:
30132352
42.

Association between Atopic Dermatitis and the Metabolic Syndrome: A Systematic Review.

Ali Z, Ulrik CS, Agner T, Thomsen SF.

Dermatology. 2018;234(3-4):79-85. doi: 10.1159/000491593. Epub 2018 Aug 15. Review.

PMID:
30110673
43.

Cause-specific mortality in patients with psoriasis and psoriatic arthritis.

Skov L, Thomsen SF, Kristensen LE, Dodge R, Hedegaard MS, Kjellberg J.

Br J Dermatol. 2019 Jan;180(1):100-107. doi: 10.1111/bjd.16919. Epub 2018 Sep 26.

PMID:
29947129
44.

Patient expectations and determinants of patient satisfaction in a dermatology outpatient clinic.

Søndergaard MB, Ghazanfar MN, Thomsen SF.

J Eur Acad Dermatol Venereol. 2019 Jan;33(1):e32-e33. doi: 10.1111/jdv.15144. Epub 2018 Jul 30. No abstract available.

PMID:
29923232
45.

Therapeutic Response to Secukinumab in a 36-Year-Old Woman with Hidradenitis Suppurativa.

Jørgensen AR, Yao Y, Thomsen SF.

Case Rep Dermatol Med. 2018 Apr 16;2018:8685136. doi: 10.1155/2018/8685136. eCollection 2018.

46.

Comorbidities in vitiligo: comprehensive review.

Dahir AM, Thomsen SF.

Int J Dermatol. 2018 Oct;57(10):1157-1164. doi: 10.1111/ijd.14055. Epub 2018 May 28. Review.

PMID:
29808541
47.

The Use and Safety of TNF Inhibitors during Pregnancy in Women with Psoriasis: A Review.

Johansen CB, Jimenez-Solem E, Haerskjold A, Sand FL, Thomsen SF.

Int J Mol Sci. 2018 May 3;19(5). pii: E1349. doi: 10.3390/ijms19051349. Review.

48.

Effectiveness of omalizumab in chronic spontaneous urticaria assessed with patient-reported outcomes: a prospective study.

Ghazanfar MN, Holm JG, Thomsen SF.

J Eur Acad Dermatol Venereol. 2018 Oct;32(10):1761-1767. doi: 10.1111/jdv.15045. Epub 2018 May 29.

PMID:
29729103
49.

A note on improvement in dermatology life quality index (DLQI) among patients with hidradenitis suppurativa treated with adalimumab.

Thomsen SF.

J Dermatolog Treat. 2018 Dec;29(8):823-824. doi: 10.1080/09546634.2018.1467537. Epub 2018 May 7. No abstract available.

PMID:
29671663
50.

Epigenetic control of IL-23 expression in keratinocytes is important for chronic skin inflammation.

Li H, Yao Q, Mariscal AG, Wu X, Hülse J, Pedersen E, Helin K, Waisman A, Vinkel C, Thomsen SF, Avgustinova A, Benitah SA, Lovato P, Norsgaard H, Mortensen MS, Veng L, Rozell B, Brakebusch C.

Nat Commun. 2018 Apr 12;9(1):1420. doi: 10.1038/s41467-018-03704-z.

Supplemental Content

Loading ...
Support Center